In this multi-center , randomized , double-blind , double-dummy , active-controlled , parallel-group study , after @-week open-label treatment with fluvastatin IR @ mg once daily , patients who did not reach their lipid goals were randomized to @-week double-blind treatment with fluvastatin XL @ mg once daily or fluvastatin IR @ mg twice daily .